BioWorld

Oct. 8, 2002

View Archived Issues

McClellan Breezes Through First Meeting Before Senate Committee

WASHINGTON - Nominee Mark McClellan easily jumped the first hurdle in becoming the next commissioner of the FDA from a largely absent Senate committee. (Bioworld Today) Read More

New Erbitux Trials Starting; ImClone Has Second Chance'

Read More

Phylogeny Test Opens Novel Path To Forensic Crime Detection, First In U.S.; Forecast As Future Model

Read More

Cell Therapeutics Starts NSCLC Phase III, Eyes One More In 2002

Read More

Quorex Enhances Platform By Acquiring Bioinformatics Firm

Read More

Other News To Note

Read More

Appointments And Advancements

Read More